On August 20, 2025 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported that members of company management will participate in the following investor events (Press release, Tyra Biosciences, AUG 20, 2025, View Source [SID1234655411]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Virtual H.C. Wainwright "HCW@Home" series
Format: Fireside chat
Presentation Date/Time: Thursday, August 21, 2025, at 11 AM ET
H.C. Wainwright 27th Annual Global Investment Conference
Format: Fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, September 10, 2025, at 9 AM ET
Location: New York, NY
A live webcast of the events can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.